Unknown OBSERVATIONAL NCT04265495

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !? a Prospective Randomized Controlled Comparative Study

Sponsor: Al Baraka Fertility Hospital

Conditions IVF

Updated 8 times since 2020 Last updated: Sep 27, 2021 Started: Feb 9, 2020 Primary completion: Nov 30, 2021 Completion: Dec 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04265495, this observational or N/A phase trial focuses on IVF and remains ongoing. Sponsored by Al Baraka Fertility Hospital, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Oct 2021 — Oct 2023 [monthly]

Recruiting
Jan 2021 — Oct 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Dec 2020 — Jan 2021 [monthly]

Recruiting
Aug 2020 — Dec 2020 [monthly]

Recruiting
Mar 2020 — Aug 2020 [monthly]

Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Al Baraka Fertility Hospital

Data source: Al Baraka Fertility Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manama, Bahrain